Meloxicam Lador (Meloxicam)

Meloxicam works by reversibly inhibiting cyclooxygenase enzymes, especially COX‑2, which reduces the synthesis of prostaglandins—key mediators of inflammation, pain, and fever. Lower prostaglandin levels result in decreased swelling and pain at the site of tissue injury.

The appropriate dose of meloxicam is determined by the prescribing healthcare professional based on the patient’s condition, severity, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for meloxicam in pregnancy and lactation are limited, and the drug is generally not recommended for use unless the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Meloxicam Lador, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Meloxicam offers preferential COX‑2 inhibition, which can provide comparable anti‑inflammatory efficacy to non‑selective NSAIDs while potentially reducing gastrointestinal irritation. However, individual response varies, and clinicians consider patient‑specific risk factors such as cardiovascular history, renal function, and gastrointestinal tolerance when selecting an NSAID.

Meloxicam Lador should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Meloxicam Lador is taken orally, usually with a full glass of water. It may be taken with or without food, but if gastrointestinal upset occurs, taking it with meals can help. Patients should swallow the tablet whole and not crush or chew it.

Serious risks include gastrointestinal ulceration or bleeding, severe skin reactions such as Stevens‑Johnson syndrome, cardiovascular events like heart attack or stroke, and renal impairment. Patients should seek immediate medical attention if they experience symptoms such as black stools, severe rash, chest pain, or sudden swelling.

Meloxicam should be avoided in individuals with active gastrointestinal ulcer disease, known hypersensitivity to meloxicam or other NSAIDs, severe renal or hepatic impairment, and those with a history of cardiovascular events unless specifically advised by a physician. It is also contraindicated during the third trimester of pregnancy.